Robert A Baldock

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Pseudomonas Aeruginosa

Top Venues

Expert opinion on drug discovery

Antibiotics (Basel, Switzerland)

Methods and protocols

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Sattaporn Weawsiangsang, Nontaporn Rattanachak, Sukunya Ross, Gareth Michael Ross, Robert A Baldock, Touchkanin Jongjitvimol, Jirapas Jongjitwimol
Hydroquinine Enhances the Efficacy of Contact Lens Solutions for Inhibiting Pseudomonas aeruginosa Adhesion and Biofilm Formation. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Sattaporn Weawsiangsang, Nontaporn Rattanachak, Sukunya Ross, Gareth Michael Ross, Robert A Baldock, Touchkanin Jongjitvimol, Jirapas Jongjitwimol
Hydroquinine Enhances the Efficacy of Contact Lens Solutions for Inhibiting Pseudomonas aeruginosa Adhesion and Biofilm Formation. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Nontaporn Rattanachak, Sattaporn Weawsiangsang, Robert A Baldock, Theerasak Jaifoo, Touchkanin Jongjitvimol, Jirapas Jongjitwimol
A Novel and Quantitative Detection Assay ( effluxR ) for Identifying Efflux-Associated Resistance Genes Using Multiplex Digital PCR in Clinical Isolates of Pseudomonas aeruginosa . Methods and protocols 6 (5) (2023)
Jirapas Jongjitwimol, Robert A Baldock
Hydroquinine: a potential new avenue in drug discovery for drug-resistant bacteria? Expert opinion on drug discovery 18 (3) (2023)
Jirapas Jongjitwimol, Robert A Baldock
Hydroquinine: a potential new avenue in drug discovery for drug-resistant bacteria? Expert opinion on drug discovery 18 (3) (2023)
Jirapas Jongjitwimol, Robert A Baldock
Hydroquinine: a potential new avenue in drug discovery for drug-resistant bacteria? Expert opinion on drug discovery (2023)
Jirapas Jongjitwimol, Robert A Baldock
Hydroquinine: a potential new avenue in drug discovery for drug-resistant bacteria? Expert opinion on drug discovery 18 (3) (2023)
Jirapas Jongjitwimol, Robert A Baldock
Hydroquinine: a potential new avenue in drug discovery for drug resistant bacteria? Expert opinion on drug discovery (2023)
Sattaporn Weawsiangsang, Nontaporn Rattanachak, Touchkanin Jongjitvimol, Theerasak Jaifoo, Pensri Charoensit, Jarupa Viyoch, Sukunya Ross, Gareth Michael Ross, Robert A Baldock, Jirapas Jongjitwimol
Hydroquinine Inhibits the Growth of Multidrug-Resistant Pseudomonas aeruginosa via the Suppression of the Arginine Deiminase Pathway Genes. International journal of molecular sciences 24 (18) (2023)
Kathrin Allkanjari, Robert A Baldock
Beyond base excision repair: an evolving picture of mitochondrial DNA repair. Bioscience reports 41 (10) (2022)
Nontaporn Rattanachak, Sattaporn Weawsiangsang, Touchkanin Jongjitvimol, Robert A Baldock, Jirapas Jongjitwimol
Hydroquinine Possesses Antibacterial Activity, and at Half the MIC, Induces the Overexpression of RND-Type Efflux Pumps Using Multiplex Digital PCR in Pseudomonas aeruginosa . Tropical medicine and infectious disease 7 (8) (2022)
Cecilia Bove, Robert A Baldock, Oscar Champigneulle, Linda Martin, Charles L Bennett
Fluoroquinolones: old drugs, putative new toxicities. Expert opinion on drug safety (2022)
Nontaporn Rattanachak, Sattaporn Weawsiangsang, Krai Daowtak, Yordhathai Thongsri, Sukunya Ross, Gareth Ross, Nungruthai Nilsri, Robert A Baldock, Sutatip Pongcharoen, Touchkanin Jongjitvimol, Jirapas Jongjitwimol
High-Throughput Transcriptomic Profiling Reveals the Inhibitory Effect of Hydroquinine on Virulence Factors in Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 11 (10) (2022)
Nicolas Bigot, Matthew Day, Robert A Baldock, Felicity Z Watts, Antony W Oliver, Laurence H Pearl
Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint. eLife 8 (2019)